Scientists Discover New Way To Target Hard-To-Treat Cancers
Recent advancements in cancer research have unveiled innovative strategies to combat hard-to-treat cancers, offering renewed hope to patients with limited treatment options. These breakthroughs span various approaches, including targeted therapies, nanotechnology, immunotherapy, and the exploitation of genetic vulnerabilities. Targeting KRAS Mutations with PROTACs KRAS mutations are implicated in approximately 17% to 25% of all cancers, driving uncontrolled tumor growth. Traditional treatments have been largely ineffective against these mutations. However, researchers have developed a molecule named ACBI3, utilizing PROTACs (PRoteolysis TArgeting Chimeras), which can degrade 13 of the 17 most common KRAS mutations with high potency and selectivity. This approach represents a significant advancement in targeting previously "undruggable" cancer proteins. The Brighter Side of News Antibody-Drug Conjugates (ADCs) for Precision Therapy ADCs are an emerging class of ...